Add to Favourites
To login click here
XtalPi and Edelweiss Connect have announced a strategic partnership to create market-leading skincare product safety assessment solutions by integrating machine learning, AI, in vitro assays and high-content cellular imaging analysis technology. The collaboration seeks to provide more accurate and reliable integrated in silico and in vitro assessment “New Approach Methods” (NAMs) in lieu of animal testing and establish new industry standards to ensure the robust fit-for-purpose adoption of such new tools in risk assessment.
